Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine

Weena J. Y. Chen; Michaela Diamant; Karin de Boer; Hendrik J. Harms; Lourens F. H. J. Robbers; Albert C. van Rossum; Mark H. H. Kramer; Adriaan A. Lammertsma; Paul Knaapen

doi:10.1186/s12933-017-0549-z

Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine

Weena J. Y. Chen, Michaela Diamant, Karin de Boer, Hendrik J. Harms, Lourens F. H. J. Robbers, Albert C. van Rossum, Mark H. H. Kramer, Adriaan A. Lammertsma, Paul Knaapen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	67
Journal	Cardiovascular Diabetology
Volume	16
DOIs	https://doi.org/10.1186/s12933-017-0549-z
Publication status	Published - 19 May 2017

Access to Document

10.1186/s12933-017-0549-z

Cite this

Chen, W. J. Y., Diamant, M., de Boer, K., Harms, H. J., Robbers, L. F. H. J., van Rossum, A. C., Kramer, M. H. H., Lammertsma, A. A., & Knaapen, P. (2017). Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine. Cardiovascular Diabetology, 16, [67]. https://doi.org/10.1186/s12933-017-0549-z

@article{7d851079074146f6a08a4acc76a4e14c,

title = "Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine",

keywords = "Diabetes mellitus type 2, Exenatide, Cardiac function, Myocardial perfusion, Myocardial oxidative metabolism",

author = "Chen, {Weena J. Y.} and Michaela Diamant and {de Boer}, Karin and Harms, {Hendrik J.} and Robbers, {Lourens F. H. J.} and {van Rossum}, {Albert C.} and Kramer, {Mark H. H.} and Lammertsma, {Adriaan A.} and Paul Knaapen",

year = "2017",

month = may,

day = "19",

doi = "10.1186/s12933-017-0549-z",

language = "English",

volume = "16",

journal = "Cardiovascular Diabetology",

issn = "1475-2840",

publisher = "BioMed Central",

}

Chen, WJY, Diamant, M, de Boer, K, Harms, HJ, Robbers, LFHJ , van Rossum, AC , Kramer, MHH , Lammertsma, AA & Knaapen, P 2017, 'Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine', Cardiovascular Diabetology, vol. 16, 67. https://doi.org/10.1186/s12933-017-0549-z

Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine. / Chen, Weena J. Y.; Diamant, Michaela; de Boer, Karin et al.

In: Cardiovascular Diabetology, Vol. 16, 67, 19.05.2017.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine

AU - Chen, Weena J. Y.

AU - Diamant, Michaela

AU - de Boer, Karin

AU - Harms, Hendrik J.

AU - Robbers, Lourens F. H. J.

AU - van Rossum, Albert C.

AU - Kramer, Mark H. H.

AU - Lammertsma, Adriaan A.

AU - Knaapen, Paul

PY - 2017/5/19

Y1 - 2017/5/19

KW - Diabetes mellitus type 2

KW - Exenatide

KW - Cardiac function

KW - Myocardial perfusion

KW - Myocardial oxidative metabolism

U2 - 10.1186/s12933-017-0549-z

DO - 10.1186/s12933-017-0549-z

M3 - Article

C2 - 28526033

SN - 1475-2840

VL - 16

JO - Cardiovascular Diabetology

JF - Cardiovascular Diabetology

M1 - 67

ER -